Saperos (603168.SH): Terbutaline sulfate solution for nebulized inhalation completed drug registration

Zhitongcaijing · 09/02/2025 08:09

Zhitong Finance App News, ShapeAce (603168.SH) announced that the company has received a “Drug Registration Certificate” for terbutaline sulfate atomized inhalation solution issued by the State Drug Administration. The approved terbutaline sulfate solution for inhalation can relieve bronchospasm associated with bronchial asthma, chronic bronchitis, emphysema, and other lung diseases.